Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
スポンサーリンク
概要
- 論文の詳細を見る
- 2011-02-01
著者
-
Soma T
Department Of Medicine National Hospital Organization Osaka Minami Medical Center
-
Soma Toshihiro
大阪大学 医学系研究科
-
Soma Toshihiro
Medicine Iii Osaka University Medical School
-
岡田 昌也
兵庫医科大学総合内科学血液・腫瘍科
-
KAIDA Katsuji
Division of Hematology, Department of Internal Medicine, Hyogo College of Medicine
-
Itoh K
Division Of Oncology And Hematology National Cancer Center Hospital East
-
Itoh Kuniaki
神戸大学 医学研究科腫瘍内科学
-
Okada Masaya
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Okada Masaya
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ichimura Koichi
Department Of Hematology And Rheumatology Tohoku University Graduate School Of Medicine
-
Ishizawa Kenichi
東北大学 血液･免疫病学分野
-
Ishizawa K
Department Of Rheumatology And Hematology
-
TANIGUCHI Kyoko
Division of Hematology and Oncology, Department of Medicine, Kyoto Prefectural University of Medicin
-
Kawase Ichiro
Department Of Respiratory Medicine Allergy Rheumatic Diseases Osaka University Graduate School Of Me
-
Itoh Kuniaki
Hematology And Oncology Division National Cancer Center Hospital East
-
Itoh Kuniaki
Department Of Chemistry Faculty Of Science Kobe University
-
Kawase Ichiro
大阪大学 医学系研究科機能診断科学
-
Tamaki Hiroya
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ogawa Hiroyasu
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Ogawa Hiroyasu
Laboratory Of Cell Transplantation Institute For Advanced Medical Sciences Hyogo College Of Medicine
-
Ogawa Hiroyasu
北福島医療センター
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine Dentistry And Pharmaceutical
-
Ikegame K
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Ikegame Kazuhiro
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
岡田 昌也
兵庫医科大学病院血液内科
-
Yoshihara Satoshi
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Yoshihara Satoshi
Department Of Molecular Medicine Osaka University Graduate School Of Medicine
-
Ichimura Koichi
Department Of Pathology Okayama University Graduate School Of Medicine And Dentistry
-
Taniguchi Kyoko
Department Of Molecular Hematology And Oncology Graduate School Of Medical Science Kyoto Prefectural
-
Ichimura Koichi
Department Of Pathology And Molecular Diagnostics Aichi Cancer Center
-
Ichimura Kouichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Shirakata Toshiaki
Department Of Cancer Immunotherapy Osaka University Graduate School Of Medicine
-
TAKATSUKA Hiroyuki
Koito Manufacturing Co. Ltd
-
Satake Atsushi
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Satake Atsushi
Department Of Hematology/oncology Osaka Medical Center For Cancer And Cardiovascular Diseases
-
Satake Atsushi
Division Of Hematology And Oncology Department Of Internal Medicine Hyogo College Of Medicine
-
Ogawa Hiroyasu
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Kaida Katsuji
Division Of Hematology Department Of Internal Medicine Hyogo College Of Medicine
-
Fujimori Yoshihiro
Laboratory Of Cell Transplantation Institute Of Advanced Medical Sciences Hyogo College Of Medicine
-
SOMA Toshihiro
Division of Hematology, Department of Internal Medicine. Hyogo College of Medicine
-
Fujimori Yoshihiro
Laboratory Of Cell Transplantation Institute For Advanced Medical Sciences Hyogo College Of Medicine
-
Ichimura Koichi
Department Of Pathology Okayama University Medical School And Graduate School Of Medicine Dentistry
-
Taniguchi Kyoko
Division Of Hematology Department Of Internal Medicine. Hyogo College Of Medicine
-
Itoh Kuniaki
Division of Hematology and Oncology, National Cancer Center Hospital East
-
YOSHIHARA Satoshi
Division of Hematology, Department of Internal Medicine. Hyogo College of Medicine
-
SOMA Toshihiro
Division of Hematology, Department of Internal Medicine, Hyogo Medical College
関連論文
- Randomized trial of response-oriented individualized versus fixed-schedule induction chemotherapy with idarubicin and cytarabine in adult acute myeloid leukemia : the JALSG AML95 study
- 9年後対側に再発した異時性両側精巣悪性リンパ腫の1例
- Extreme eosinophilia caused by interleukin-5-producing disseminated colon cancer
- 同種骨髄移植後のhuman herpes virus-6血症患者に発症したbronchioltis obliterans organizing pneumonia (BOOP)様肺病変
- Phase I and II pharmacokinetic and pharmacodynamic study of the proteasome inhibitor bortezomib in Japanese patients with relapsed or refractory multiple myeloma
- 小児および成人造血器悪性腫瘍に対する非血縁さい帯血移植の比較検討
- Clonal Analysis of Bilateral, Recurrent, or Systemically Multifocal Ocular Adnexal Lymphoma
- Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
- Successful treatment of relapsed T-cell non-Hodgkin's lymphoma with allogeneic peripheral blood stem cell transplantation with double conditioning
- Different Kinetics of WT1 and PML-RARα Gene Expression Levels during Remission Induction Therapy with All-trans Retinoic Acid Alone in Acute Promyelocytic Leukemia
- Effect of heparin addition on expansion of cord blood hematopoietic progenitor cells in three-dimensional coculture with stromal cells in nonwoven fabrics
- Monitoring Minimal Residual Disease in Leukemia Using Real-time Quantitative Polymerase Chain Reaction for Wilms Tumor Gene (WT1)
- Analysis of Hematopoietic Microenvironment Containing Spatial Development of Stromal Cells in Nonwoven Fabrics (ANIMAL BIOTECHNOLOGY)
- Lethal Adenovirus Infection in a Patient Who Had Undergone Nonmyeloblative Stem Cell Transplantation
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
- Expression of the Wilms' Tumor Gene WT1 in Solid Tumors and Its Involvement in Tumor Cell Growth
- Prognostic analysis and a new risk model for Hodgkin lymphoma in Japan
- 同種骨髄移植における GVHD 予防法の検討
- 骨髄移植後の気管支肺胞洗浄液におけるリンパ球CD4/CD8比とサイトメガロウイルス感染との関連性
- 骨髄移植とサイトメガロウイルス感染 : 感染の危険因子
- 非血縁者間骨髄移植におけるCMV感染とpre - emptive therapy
- 骨髄移植患者における気管支肺胞洗浄液を用いたサイトメガロウイルス抗原検索によるCMV感染のモニタリングに関する検討
- Cyclophosphamideとウサギ抗ヒト胸腺細胞免疫グロブリンの前処置にて緊急に骨髄移植を施行した肺炎合併の重症再生不良性貧血
- Phase I Study of Intravenous PSC-833 and Doxorubicin: Reversal of Multidrug Resistance
- A Phase I/II study of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL
- Severe hypogammaglobulinemia persisting for 6 years after treatment with rituximab combined chemotherapy due to arrest of B lymphocyte differentiation together with alteration of T lymphocyte homeostasis
- Acquired hemophilia A with sigmoid colon cancer : successful treatment with rituximab followed by sigmoidectomy
- A retrospective analysis of bortezomib therapy for Japanese patients with relapsed or refractory multiple myeloma : β2-microglobulin associated with time to progression
- Dose Modification of Imatinib by Monitoring the Level of BCR-ABL Transcript in Chronic Myelogenous Leukemia
- Increased Expression of Insulin-Like Growth Factor I is Associated with Ara-C Resistance in Leukemia
- Imatinib Mesylate in Conjunction with Allogeneic Hematopoietic Stem Cell Transplantation in Patients with Philadelphia Chromosome Positive Leukemias : Report of 4 Cases
- Detection of Clone-Specific Immunoglobulin Heavy Chain Genes in the Bone Marrow of B-cell-Lineage Lymphoma after Treatment
- High Expression of YB-1 Gene in Erythroid Cells in Patients with Refractory Anemia
- Separation of antileukemic effects from graft-versus-host disease in MHC-haploidentical murine bone marrow transplantation : participation of host immune cells
- Phase I study of radioimmunotherapy with an anti-CD20 murine radioimmunoconjugate (^Y-ibritumomab tiuxetan) in relapsed or refractory indolent B-cell lymphoma
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Japanese phase II study of ^Y-ibritumomab tiuxetan in patients with relapsed or refractory indolent B-cell lymphoma
- Imatinib for newly diagnosed chronic-phase chronic myeloid leukemia : results of a prospective study in Japan
- Case-control study of leukemia and diagnostic radiation exposure
- Phase III Study of Ranimustine, Cyclophosphamide, Vincristine, Melphalan, and Prednisolone (MCNU-COP/MP) versus Modified COP/MP in Multiple Myeloma : A Japan Clinical Oncology Group Study, JCOG 9301
- Randomized phase II study of concurrent and sequential rituximab and CHOP chemotherapy in untreated indolent B-cell lymphoma
- Phenotypic analysis of peripheral T/NK cell lymphoma : Study of 408 Japanese cases with special reference to their anatomical sites
- Morphological spectrum of cyclin D1-positive mantle cell lymphoma : Study of 168 cases
- Population pharmacokinetics of docetaxel in patients with hepatic dysfunction treated in an oncology practice
- Pharmacokinetics and pharmacodynamics of protein-unbound docetaxel in cancer patients
- Extragonadal germ cell tumors in Japan
- Treatable Subsets in Cancer of Unknown Primary Origin
- Toxicity and efficacy of ifosfamide, carboplatin and etoposide (modified ICE) as a salvage chemotherapy in Japanese patients with relapsed or refractory aggressive non-Hodgkin's lymphoma
- Recurrent Breast Cancer Treated Successfully with Mitomycin-C and Vinblastine after Failure of Both Doxorubicin-containing Regimen and Paclitaxel : A Case Report
- A Limited Sampling Model for Estimating Pharmacokinetics of CPT-11 and Its Metabolite SN-38
- Pharmacological Correlation between Total Drug Concentration and Lactones of CPT-11 and SN-38 in Patients Treated with CPT-11
- Sensitive immunohistochemical detection of WT1 protein in tumors with anti-WT1 antibody against WT1 235 peptide
- High frequencies of less differentiated and more proliferative WT1-specific CD8^+ T Cells in bone marrow in tumor-bearing patients : An important role of bone marrow as a secondary lymphoid organ
- Safety and efficacy of rasburicase (SR29142) in a Japanese phase II study
- Biased usage of BV gene families of T-cell receptors of WT1 (Wilms' tumor gene)-specific CD8^+ T cells in patients with myeloid malignancies
- P2-163 ラジオアイソトープ標識抗体療法剤ゼヴァリン^[○!R]イットリウムによる血球減少の調査(一般演題 ポスター発表,有害事象・副作用,臨床から学び臨床へと還元する医療薬学)
- Fludarabine- and Cyclophosphamide-Based Nonmyelobalative Conditioning Regimen for Transplantation of Chronic Granulomatous Disease : Possible Correlation with Prolonged Pure Red Cell Aplasia
- Microbial Serine Carboxypeptidase Inhibitors : Comparative Analysis of Actions on Homologous Enzymes Derived from Man, Yeast and Wheat
- Reduced-Intensity Conditioning Followed by Unrelated Umbilical Cord Blood Transplantation for Advanced Hematologic Malignancies : Rapid Engraftment in Bone Marrow
- Clinical, biochemical, and cytochemical studies on a Japanese Salla disease case associated with a renal disorder
- Relationships between Hematological Recovery and Overall Survival in Older Adults Undergoing Allogeneic Bone Marrow Transplantation
- Forum 第31回日本造血細胞移植学会ランチョンセミナー Ph[+]白血病に対する新規チロシンキナーゼ阻害薬ダサチニブの治療戦略
- Overexpression of the Wilms' tumor gene WT1 in primary astrocytic tumors
- Wilms Tumor Gene WT1 Peptide-Based Immunotherapy Induced a Minimal Response in a Patient with Advanced Therapy-Resistant Multiple Myeloma
- Wilms' tumor gene WT1 17AA(-)/KTS(-) isoform induces morphological changes and promotes cell migration and invasion in vitro
- Photo-Induced Reactions of Oxime O-Ethers Derived from 3-Acyl-1, 2-dihydrocinnoline- 1, 2-dicarboximides
- Novel Photo-Rearrangement of Oxime Methyl Ethers of 3-Acyl-1, 2dihydrocinnoline-N-phenyl-1, 2-dicarboximides
- WT1 (Wilms' Tumor 1) Peptide Immunotherapy for Renal Cell Carcinoma
- Positron Emission Tomography/Computed Tomography after Immunocytochemical and Clonal Diagnosis of Intraocular Lymphoma with Vitrectomy Cell Blocks
- Phase II study of oral fludarabine in combination with rituximab for relapsed indolent B-cell non-Hodgkin lymphoma
- Phase I/II and pharmacokinetic study of cladribine with 2-h infusion in Japanese patients with relapsed indolent B-cell lymphoma mostly pretreated with rituximab
- Serum soluble interleukin-2 receptor level and immunophenotype are prognostic factors for patients with diffuse large B-cell lymphoma
- Frequent downregulation or loss of CD79a expression in plasma cell myelomas : Potential clue for diagnosis
- Correlation Between Histological Evaluation and PCR-based Clonality Analysis of Gastric MALT Lymphomas Treated by Eradication of Helicobacter pylori
- Immunoglobulin G4 (IgG4)-Positive or -Negative Ocular Adnexal Benign Lymphoid Lesions in Relation to Systemic Involvement
- イマチニブに対して Late Suboptimal Response を示した慢性期CML症例に対する治療選択
- Phase I study of the oral mammalian target of rapamycin inhibitor everolimus (RAD001) in Japanese patients with relapsed or refractory non-Hodgkin lymphoma
- Phase II study of ABVd therapy for newly diagnosed clinical stage II-IV Hodgkin lymphoma : Japan Clinical Oncology Group study (JCOG 9305)
- Randomized phase II study of concurrent and sequential combinations of rituximab plus CHOP (cyclophosphamide, doxorubicin, vincristine and prednisolone) chemotherapy in untreated indolent B-cell non-Hodgkin lymphoma : 7-year follow-up results
- Multicenter phase II study of bendamustine for relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma
- Identification of a WT1 protein-derived peptide, WT1_, : as a HLA-A^*0206-restricted, WT1-specific CTL epitope
- BAFF-R is Expressed on B-cell Lymphomas Depending on their Origin, and its Related to Proliferation Index of Nodal Diffuse Large B-cell Lymphomas
- A WT1 protein-derived, naturally processed 16-mer peptide, WT1_, is a promiscuous helper peptide for induction of WT1-specific Th1-type CD4^+ T cells
- Comparison of Long-Term Clinical Outcomes of CHOP Chemotherapy between Japanese Patients with Nodal Peripheral T-Cell Lymphomas and Those with Diffuse Large B-Cell Lymphoma in the Study Group of the Tohoku Hematology Forum
- Bilateral Conjunctival Lesions in Blastic Plasmacytoid Dendritic Cell Neoplasm
- Clinicopathological Features of Malignant Lymphoma in Japan : The Miyagi Study
- Relevance of monitoring metabolic reduction in patients with relapsed or refractory follicular and mantle cell lymphoma receiving bendamustine : a multicenter study
- Lack of non-hematological cross intolerance of dasatinib to imatinib in imatinib-intolerant patients with Philadelphia chromosome positive chronic myeloid leukemia or acute lymphatic leukemia : a retrospective safety analysis
- Direct antiglobulin test-negative autoimmune hemolytic anemia associated with HLA-haploidentical stem cell transplantation
- Use of mycophenolate mofetil in patients received allogeneic hematopoietic stem cell transplantation in Japan
- Successful treatment with nilotinib after imatinib failure in a CML patient with a four-way Ph chromosome translocation and point mutations in BCR/ABL gene
- Neurotoxins, 1-methy1-4-phenyl-1, 2, 3, 6-tetrahydropyridine, 1, 2, 3, 4, -tetrahydroisoquinoline, N-methyl-tetrahydroisoquinoline and 1-benzyl-tetrahydroisoquinoline, are substrates for rat liver flavin-containing monooxygenase(FMO) expressed in yeast
- 座談会 濾胞性リンパ腫に対する治療戦略
- Rituximab monotherapy with eight weekly infusions for relapsed or refractory patients with indolent B cell non-Hodgkin lymphoma mostly pretreated with rituximab : A multicenter phase II study
- Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue
- 重篤な鼻出血から診断されたアグレッシブNK細胞白血病例
- Strategy for bone marrow transplantation in eculizumab-treated paroxysmal nocturnal hemoglobinuria
- Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL : a 36-month analysis of a phase I and II study
- Diagnosis of Intestinal Graft-versus-Host Disease and Thrombotic Microangiopathy after Allogeneic Stem Cell Transplantation
- Feasibility of unmanipulated haploidentical stem cell transplantation using standard GVHD prophylaxis for HLA-homozygous patients